Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 13;23(8):3971.
doi: 10.3390/s23083971.

Sensing of Catecholamine in Human Urine Using a Simple Colorimetric Assay Based on Direct Melanochrome and Indolequinone Formation

Affiliations

Sensing of Catecholamine in Human Urine Using a Simple Colorimetric Assay Based on Direct Melanochrome and Indolequinone Formation

Mariagrazia Lettieri et al. Sensors (Basel). .

Abstract

We used the first enzyme-free synthesis and stabilization of soluble melanochrome (MC) and 5,6-indolequinone (IQ) derived from levodopa (LD), dopamine (DA), and norepinephrine (NE) oxidation to develop a simple colorimetric assay for catecholamine detection in human urine, also elucidating the time-dependent formation and molecular weight of MC and IQ using UV-Vis spectroscopy and mass spectrometry. The quantitative detection of LD and DA was achieved in human urine using MC as a selective colorimetric reporter to demonstrate the potential assay applicability in a matrix of interest in therapeutic drug monitoring (TDM) and in clinical chemistry. The assay showed a linear dynamic range between 5.0 mg L-1 and 50.0 mg L-1, covering the concentration range of DA and LD found in urine samples from, e.g., Parkinson's patients undergoing LD-based pharmacological therapy. The data reproducibility in the real matrix was very good within this concentration range (RSDav% 3.7% and 6.1% for DA and LD, respectively), also showing very good analytical performances with the limits of detection of 3.69 ± 0.17 mg L-1 and 2.51 ± 0.08 mg L-1 for DA and LD, respectively, thus paving the way for the effective and non-invasive monitoring of dopamine and levodopa in urine from patients during TDM in Parkinson's disease.

Keywords: Parkinson’s disease; catecholamines oxidation; colorimetric assay; dopamine; indolequinone; levodopa; melanochrome; norepinephrine; therapeutic drug monitoring; urine analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Time-dependent oxidation of natural catecholamines 0.2 g L−1 in DMSO:H2O 1:1 (v/v) in the presence of 150 mM Mg(Ac)2, 150 mM NH4Cl at pH 9.4 and 25 °C between 2 min and 144 min. UV–Vis spectra (upper panels) and absorbance values (lower panels) at 340 nm (orange circles/dashed line) and 590 nm (purple circles/dashed lines) for dopamine (DA), levodopa (LD), and norepinephrine (NE).
Figure 2
Figure 2
Catecholamines calibration curves in human urine spiked with levodopa (LD, purple circles), dopamine (DA, white circles), and norepinephrine (NE, orange circles), from 5.0 to 50.0 mg L−1, and dilute 1:8 (v/v) with a proper buffer (150 mM Mg(Ac)2, 150 mM NH4Cl at pH 9.4 in DMSO:H2O 1:1 (v/v)) [4]. Absorbance at 585 nm was acquired at 25 °C after 15 min of solution mixing. Each point represents the mean ± SD (n = 4).

Similar articles

Cited by

References

    1. Yan T., Zhang G., Chai H., Qu L., Zhang X. Flexible biosensors based on colorimetry, fluorescence, and electrochemistry for point-of-care testing. Front. Bioeng. Biotechnol. 2021;9:753692. doi: 10.3389/fbioe.2021.753692. - DOI - PMC - PubMed
    1. Zhou Y., Huang X., Hu X., Tong W., Leng Y., Xiong Y. Recent advances in colorimetry/fluorimetry-based dual-modal sensing technologies. Biosens. Bioelectron. 2021;190:113386. doi: 10.1016/j.bios.2021.113386. - DOI - PubMed
    1. Doménech-Carbó M.T., Doménech-Carbó A. Spot tests: Past and present. ChemTexts. 2022;8:4. doi: 10.1007/s40828-021-00152-z. - DOI - PMC - PubMed
    1. Lettieri M., Scarano S., Palladino P., Minunni M. Colorimetric determination of carbidopa in anti-Parkinson drugs based on 4-hydroxy-3-methoxybenzaldazine formation by reaction with vanillin. Anal. Bioanal. Chem. 2022;414:6911–6918. doi: 10.1007/s00216-022-04256-4. - DOI - PMC - PubMed
    1. Lettieri M., Emanuele R., Scarano S., Palladino P., Minunni M. Melanochrome-based colorimetric assay for quantitative detection of levodopa in co-presence of carbidopa and its application to relevant anti-Parkinson drugs. Anal. Bioanal. Chem. 2022;414:1713–1722. doi: 10.1007/s00216-021-03804-8. - DOI - PubMed